Tumour necrosis factor α confers an invasive, transformed phenotype on mammary epithelial cells

Journal of Cell Science

Volumn 118, Issue 15, 2005, Pages 3487-3500

  Montesano, Roberto ^a   Soulié, Priscilla ^a   Eble, Johannes A ^b   Carrozzino, Fabio ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cytokine; Integrin; Invasion; Migration; Transformation

Indexed keywords

ALPHA2 INTEGRIN; BATIMASTAT; BETA1 INTEGRIN; BLOCKING ANTIBODY; COLLAGEN GEL; COLLAGEN TYPE 1; GELATINASE B; LEUKOCYTE ANTIBODY; MATRIX METALLOPROTEINASE INHIBITOR; MITOGENIC AGENT; PROTEIN INHIBITOR; PROTEIN SUBUNIT; RHODOCETIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BREAST EPITHELIUM; CELL ADHESION; CELL ANCHORAGE; CELL CONTACT; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CELL TRANSFORMATION; CONTROLLED STUDY; CULTURE MEDIUM; EPITHELIUM CELL; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH;

ANIMALS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; INTEGRIN ALPHA2BETA1; MAMMARY GLANDS, ANIMAL; METALLOPROTEASES; MICE; PHENOTYPE; PROTEASE INHIBITORS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 24344479304     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02467     Document Type: Article

References (76)

1. Aggarwal, B. B. (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol. 3, 745-756.
2. Argast, G. M., Campbell, J. S., Brooling, J. T. and Fausto, N. (2004). Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem. 279, 34530-34536.
3. Arnott, C. H., Scott, K. A., Moore, R. J., Hewer, A., Phillips, D. H., Parker, P., Balkwill, F. R. and Owens, D. M. (2002). Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene 21, 4728-4738.
4. Baeckstrom, D., Lu, P. J. and Taylor-Papadimitriou, J. (2000). Activation of the alpha2beta1 integrin prevents c-ErbB2-induced scattering and apoptosis of human mammary epithelial cells in collagen. Oncogene 19, 4592-4603.
5. Balkwill, F. (2002). Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13, 135-141.
6. Balkwill, F. and Mantovani, A. (2001). Inflammation and cancer: back to Virchow? Lancet 357, 539-545.
7. Bates, R. C. and Mercurio, A. M. (2003). Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol. Biol. Cell 14, 1790-1800.
8. Baud, V. and Karin, M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11, 372-377.
9. Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G. and Moses, H. L. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848-851.
10. Birchmeier, C., Birchmeier, W. and Brand-Saberi, B. (1996). Epithelial-mesenchymal transitions in cancer progression. Acta Anat. 156, 217-226.
11. Bissell, M. J. and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54.
12. Brigati, C., Noonan, D. M., Albini, A. and Benelli, R. (2002). Tumors and inflammatory infiltrates: friends or foes? Clin. Exp. Metastasis 19, 247-258.
13. Brown, P. D. (1998). Synthetic inhibitors of matrix metalloproteinases. In Matrix Metalloproteinases (ed. W. C. Parks and R. P. Mecham), pp. 243-261. St Louis, MO: Academic Press.
14. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
15. Chen, J., Diacovo, T. G., Grenache, D. G., Santoro, S. A. and Zutter, M. (2002). The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am. J. Pathol. 161, 337-344.
16. Chen, W. N., Woodbury, R. L., Kathmann, L. E., Opresko, L. K., Zangar, R. C., Wiley, H. S. and Thrall, B. D. (2004). Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha. J. Biol. Chem. 279, 18488-18496.
17. Colognato, H., MacCarrick, M., O'Rear, J. J. and Yurchenco, P. D. (1997). The laminin alpha2-chain short arm mediates cell adhesion through both the alpha1beta1 and alpha2beta1 integrins. J. Biol. Chem. 272, 29330-29336.
18. Coussens, L. M. and Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860-867.
19. Creemers, L. B., Jansen, I. D., Docherty, A. J., Reynolds, J. J., Beertsen, W. and Everts, V. (1998). Gelatinase A (MMP-2) and cysteine proteinases are essential for the degradation of collagen in soft connective tissue. Matrix Biol. 17, 35-46.
20. De Wever, O. and Mareel, M. (2003). Role of tissue stroma in cancer cell invasion. J. Pathol. 200, 429-447.
21. Decline, F. and Rousselle, P. (2001). Keratinocyte migration requires alpha2beta1 integrin-mediated interaction with the laminin 5 gamma2 chain. JCS 114, 811-823.
22. Dempsey, P. W., Doyle, S. E., He, J. Q. and Cheng, G. (2003). The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14, 193-209.
23. Dranoff, G. (2004). Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer 4, 11-22.
24. Eble, J. A., Beermann, B., Hinz, H. J. and Schmidt-Hederich, A. (2001). Alpha2beta1 integrin is not recognized by rhodocytin but is the specific, high affinity target of rhodocetin, an RGD-independent disintegrin and potent inhibitor of cell adhesion to collagen. J. Biol. Chem. 276, 12274-12284.
25. Eble, J. A., Niland, S., Dennes, A., Schmidt-Hederich, A., Bruckner, P. and Brunner, G. (2002). Rhodocetin antagonizes stromal tumor invasion in vitro and other alpha2beta1 integrin-mediated cell functions. Matrix Biol. 21, 547-558.
26. Egeblad, M. and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
27. Elenbaas, B. and Weinberg, R. A. (2001). Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 264, 169-184.
28. Grunert, S., Jechlinger, M. and Beug, H. (2003). Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat. Rev. Mol. Cell Biol. 4, 657-665.
29. Gumbiner, B. M. (1996). Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84, 345-357.
30. Hay, E. D. (1995). An overview of epithelio-mesenchymal transformation. Acta Anat. 154, 8-20.
31. Inoue, O., Suzuki-Inoue, K., Dean, W. L., Frampton, J. and Watson, S. P. (2003). Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J. Cell Biol. 160, 769-780.
32. Iocca, H. A. and Isom, H. C. (2003). Tumor necrosis factor-alpha acts as a complete mitogen for primary rat hepatocytes. Am. J. Pathol. 163,, 465-476.
33. Ip, M. M., Shoemaker, S. F. and Darcy, K. M. (1992). Regulation of rat mammary epithelial cell proliferation and differentiation by tumor necrosis factor-alpha. Endocrinology 130, 2833-2844.
34. Ivaska, J. and Heino, J. (2000). Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix. Cell. Mol. Life Sci. 57, 16-24.
35. Jokinen, J., Dadu, E., Nykvist, P., Kapyla, J., White, D. J., Ivaska, J., Vehvilainen, P., Reunanen, H., Larjava, H., Hakkinen, L. et al. (2004). Integrin-mediated cell adhesion to type I collagen fibrils. J. Biol. Chem. 279, 31956-31963.
36. Kaiser, G. C. and Polk, D. B. (1997). Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line. Gastroenterology 112, 1231-1240.
37. Kawashima, A., Kawahara, E., Tokuda, R. and Nakanishi, I. (2001). Turnour necrosis factor-alpha provokes upregulation of alpha2beta1 and alpha-5beta1 integrins, and cell migration in OST osteosarcoma cells. Cell Biol. Int. 25, 319-329.
38. Lee, P. P., Hwang, J. J., Murphy, G. and Ip, M. M. (2000). Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells. Endocrinology 141, 3764-3773.
39. Leek, R. D. and Harris, A. L. (2002). Tumor-associated macrophages in breast cancer. J Mammary Gland Biol. 7, 177-189.
40. Lejeune, F. J., Ruegg, C. and Lienard, D. (1998). Clinical applications of TNF-alpha in cancer. Curr Opin. Immunol. 10, 573-580.
41. Liotta, L. A. and Kohn, E. C. (2001). The microenvironment of the tumour-host interface. Nature 411, 375-379.
42. Lochter, A., Navre, M., Werb, Z. and Bissell, M. J. (1999). Alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol. Biol. Cell 10, 271-282.
43. Locksley, R. M., Killeen, N. and Lenardo, M. J. (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501.
44. MacEwan, D. J. (2002). TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135, 855-875.
45. Maffini, M. V., Soto, A. M., Calabro, J. M., Ucci, A. A. and Sonnenschein, C. (2004). The stroma as a crucial target in rat mammary gland carcinogenesis. J. Cell Sci. 117, 1495-1502.
46. Malik, S. T., Naylor, M. S., East, N., Oliff, A. and Balkwill, F. R. (1990). Cells secreting tumour necrosis factor show enhanced metastasis in nude mice. Eur. J. Cancer 26, 1031-1034.
47. Mareel, M. and Leroy, A. (2003). Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83, 337-376.
48. Mareel, M. M., Van Roy, F. M. and Bracke, M. E. (1993). How and when do tumor cells metastasize? Crit. Rev. Oncog. 4, 559-594.
49. Montesano, R. and Orci, L. (1985). Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42, 469-477.
50. Montesano, R. and Soulie, P. (2002). Retinoids induce lumen morphogenesis in mammary epithelial cells. J. Cell. Sci. 115, 4419-4431.
51. Montesano, R., Mossaz, A., Ryser, J. E., Orci, L. and Vassalli, P. (1984). Leukocyte interleukins induce cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J. Cell Biol. 99, 1706-1715.
52. Montesano, R., Matsumoto, K., Nakamura, T. and Orci, L. (1991a). Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67, 901-908.
53. Montesano, R., Schaller, G. and Orci, L. (1991b). Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 66, 697-711.
54. Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M. et al. (1999). Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med. 5, 828-831.
55. Nista, A., Mattioni, M., Gismondi, A., Palmieri, G. and Santoni, A. (1996). Beta1-integrin expression and function in human bladder cancer cells: modulation by TNF alpha. Anticancer Res. 16, 581-588.
56. Okamoto, M. and Oyasu, R. (1997). Transformation in vitro of a nontumorigenic rat urothelial cell line by tumor necrosis factor-alpha. Lab. Invest. 77, 139-144.
57. Old, L. J. (1985). Tumor necrosis factor (TNF). Science 230, 630-632.
58. Orosz, P., Echtenacher, B., Falk, W., Ruschoff, J., Weber, D. and Manuel, D. N. (1993). Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med. 177, 1391-1398.
59. Palladino, M. A., Bahjat, R R., Theodorakis, E. A. and Moldawer, L. L. (2003). Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2, 736-746.
60. Pollard, J. W. (2004). Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
61. Rosen, E. M., Goldberg, I. D., Liu, D., Setter, E., Donovan, M. A., Bhargava, M., Reiss, M. and Kacinski, B. M. (1991). Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res. 51, 5315-5321.
62. Scott, K. A., Moore, R. J., Arnott, C. H., East, N., Thompson, R. G., Scallon, B. J., Shealy, D. J. and Balkwill, F. R. (2003). An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. Mol. Cancer Ther. 2, 445-451.
63. Szlosarek, P. W. and Balkwill, F. R. (2003). Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 4, 565-573.
64. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
65. Tlsty, T. D. (2001). Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 11, 97-104.
66. Trusolino, L. and Comoglio, P. M. (2002). Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat. Rev. Cancer 2, 289-300.
67. Unger, M. and Weaver, V. M. (2003). The tissue microenvironment as an epigenetic tumor modifier. Methods Mol. Biol. 223, 315-347.
68. Valles, A. M., Boyer, B., Tarone, G. and Thiery, J. P. (1996). Alpha 2 beta 1 integrin is required for the collagen and FGF-1 induced cell dispersion in a rat bladder carcinoma cell line. Cell Adhes. Commun. 4, 187-199.
69. Varela, L. M. and Ip, M. M. (1996). Tumor necrosis factor-alpha: a multifunctional regulator of mammary gland development. Endocrinology 137, 4915-4924.
70. Varfolomeev, E. E. and Ashkenazi, A. (2004). Tumor necrosis factor: an apoptosis JuNKie? Cell 116, 491-497.
71. Vihinen, P., Riikonen, T., Laine, A. and Heino, J. (1996). Integrin alpha 2 beta 1 in tumorigenic human osteosarcoma cell lines regulates cell adhesion, migration, and invasion by interaction with type I collagen. Cell Growth Differ. 7, 439-447.
72. Wilson, J. and Balkwill, F. (2002). The role of cytokines in the epithelial cancer microenvironment. Semin. Cancer Biol. 12, 113-120.
73. Yamada, K. M., Kennedy, D. W., Yamada, S. S., Gralnick, H., Chen, W. T. and Akiyama, S. K. (1990). Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Res. 50, 4485-4496.
74. Zettl, K. S., Sjaastad, M. D., Riskin, P. M., Parry, G., Machen, T. E. and Firestone, G. L. (1992). Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc. Natl. Acad. Sci. USA 89, 9069-9073.
75. Zhang, Y. W. and Vande Woude, G. F. (2003). HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell Biochem. 88, 408-417.
76. Zutter, M. M., Santoro, S. A., Staatz, W. D. and Tsung, Y. L. (1995). Re-expression of the alpha 2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc. Natl. Acad. Sci. USA 92, 7411-7415.